HUNTINGDON VALLEY, Pa., Nov. 10 /PRNewswire-FirstCall/ -- Cellegy Pharmaceuticals, Inc. , will be hosting a conference call beginning at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) on Tuesday, November 15, 2005. Richard C. Williams, Chairman and Interim Chief Executive Officer, and Robert J. Caso, Vice President, Finance and Chief Financial Officer will provide a business and financial update.
To participate in the live call by telephone, please dial (866) 271-6130 from the United States, or for international callers, please dial (617) 213-8894, entering the Passcode, 74113897. Those interested in listening to the conference call live via the internet may do so by visiting the Company's website at www.cellegy.com.
A replay will be available on Cellegy's website for one week. A telephone replay will be available for one week by dialing (888) 286-8010 from the United States, or (617) 801-6888 for international callers, and entering Passcode 74764213.
Cellegy Pharmaceuticals, Inc. is a specialty biopharmaceutical company that develops and commercializes prescription drugs for the treatment of women's health care conditions, including HIV prevention and sexual dysfunction, and gastrointestinal disorders.
Cellegy Pharmaceuticals, Inc.CONTACT: Robert J. Caso, Vice President, Finance & CFO, +1-215-914-0900,ext. 603, or Richard C. Williams, Chairman and Interim CEO,+1-650-616-2200, both of Cellegy Pharmaceuticals
Web site: http://www.cellegy.com/
